Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 1.00 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 1.00 |
| ▸ | LDHB | P07195 | 3/20 | 0.43 |
| ▸ | TERF2IP | Q9NYB0 | 4/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.39 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
| ▸ | NPY4R | P50391 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.39 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.39 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.39 |
| ▸ | SSTR5 | P35346 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27013344 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL18902502 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL14241069 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL7799155 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL16549195 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL23626629 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL19532503 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL15507051 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL21991628 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| Polymyxin B2 SCHEMBL29514784 | 0.99 | KDM1A (0.98) | KDM1ARCOR1LDHBTERF2IPEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 854 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025149805-A1 | PROCESS AND APPARATUS FOR MANUFACTURING FOAM DRESSINGS, FOAM DRESSINGS MADE THEREFROM, AND COMPOSITION AND PROCESS OF PREPARING FOAM PRECURSOR MIXTURES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-07-17 | — | — | WO | claimed |
| CN-119291073-B | Method for simultaneously detecting content of polymyxin and caspofungin and application of internal standard | 兰州大学第二医院 | 2025-05-13 | — | — | CN | claimed |
| CN-119827655-A | Method for measuring related substances and components of polymyxin B sulfate by adopting HPLC | 福建省福抗药业股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| CN-119667047-A | Analysis method of polymyxin B sulfate related substances for injection | 海南广升誉制药有限公司 | 2025-03-21 | — | — | CN | claimed |
| US-12220493-B2 | Nitric oxide producing collagen/ORC dressing | SYSTAGENIX WOUND MANAGEMENT, LIMITED (GB) | 2025-02-11 | — | — | US | claimed |
| CN-119291073-A | Method for simultaneously detecting content of polymyxin and caspofungin, internal standard and application thereof | 兰州大学第二医院 | 2025-01-10 | — | — | CN | claimed |
| CN-118726532-A | Culture medium for detecting clostridium perfringens and clostridium perfringens detection method | 蓝星安迪苏南京有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118501277-A | Method for determining polymyxin E1 and polymyxin E2 concentrations in human cerebrospinal fluid | 中国人民解放军空军军医大学 | 2024-08-16 | — | — | CN | claimed |
| CN-117783372-B | LC-MS/MS based method for simultaneously determining amikacin and polymyxin B in blood plasma and blood serum | 裕菁科技(上海)有限公司 | 2024-07-02 | — | — | CN | claimed |
| US-20070105154-A1 | Cell lysis composition, methods of use, apparatus, and kit | PROMEGA CORPORATION (US) | 2007-05-10 | — | — | US | claimed |
| EP-1761554-A2 | PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME | Biosource Pharm, Inc. (US) | 2007-03-14 | — | — | EP | claimed |
| US-20060269485-A1 | Antibiotic kit and composition and uses thereof | FOAMIX LTD. (IL) | 2006-11-30 | — | — | US | claimed |
| WO-2006083317-A2 | PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME | BIOSOURCE PHARM, INC. (US) | 2006-08-10 | — | — | WO | claimed |
| US-20040101947-A1 | Cell lysis composition, methods of use, apparatus and kit | PROMEGA CORPORATION | 2004-05-27 | — | — | US | claimed |
| US-6380356-B1 | DIMERS WITH GIVEN LINKING GROUPS; USE AGAINST GRAM-NEGATIVE BACTERIAL INFECTIONS | ADVANCED MEDICINE, INC. | 2002-04-30 | — | — | US | claimed |
| EP-0508724-B1 | Radiopharmaceutical bacteriostats | MERCK FROSST CANADA INC (CA) | 1996-08-07 | — | — | EP | claimed |
| EP-0508724-A1 | Radiopharmaceutical bacteriostats | MERCK FROSST CANADA INC. (CA) | 1992-10-14 | — | — | EP | claimed |
| EP-0302466-B1 | CYCLOPEPTIDES AS ABSORPTION ENHANCERS FOR ADMINISTRATION ON THE MUCOUS MEMBRANES | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-11-21 | — | — | EP | claimed |
| EP-0302466-A1 | Cyclopeptides as absorption enhancers for administration on the mucous membranes | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-02-08 | — | — | EP | claimed |